NCT01747447View on ClinicalTrials.gov

VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)

NACompletedINTERVENTIONAL
Enrollment

771

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

August 2, 2023

Conditions
Bone DensityBody CompositionBone Health
Interventions
DIETARY_SUPPLEMENT

Vitamin D3 placebo

Vitamin D placebo

DIETARY_SUPPLEMENT

Fish oil placebo

Fish oil placebo

DIETARY_SUPPLEMENT

omega-3 fatty acids (fish oil)

Omacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\]).

DIETARY_SUPPLEMENT

Vitamin D3

Vitamin D3 (cholecalciferol), 2000 IU per day.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT01747447 - VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL) | Biotech Hunter | Biotech Hunter